Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding

Journal of Nutritional Biochemistry

Volumn 37, Issue , 2016, Pages 20-29

  Drew, Janice E ^a   Farquharson, Andrew J ^a   Horgan, Graham W ^b   Williams, Lynda M ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b BIOMATHEMATICS AND STATISTICS SCOTLAND   (United Kingdom)

Author keywords

Glucose intolerance; High fat diet; Mouse; Nicotinamide adenine dinucleotide; Sirtuin

Indexed keywords

ABC TRANSPORTER A1; CD38 ANTIGEN; GLUCOSE; HORMONE; NAPRT1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE RIBOSIDE; NICOTINIC ACID; NMNAT2 PROTEIN; NMNAT3 PROTEIN; NMRK2 PROTEIN; SIRTUIN; SIRTUIN 4; SIRTUIN 7; TRYPTOPHAN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MITOCHONDRIAL PROTEIN; NICOTINAMIDE METHYLTRANSFERASE; NNMT PROTEIN, MOUSE; SIRT4 PROTEIN, MOUSE; SIRT7 PROTEIN, MOUSE; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; DIET INDUCED OBESITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; GENE EXPRESSION ASSAY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID DIET; LIPID HOMEOSTASIS; METABOLIC DISORDER; MOUSE; NONHUMAN; REGULATORY MECHANISM; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIVER; MALE; METABOLISM; OBESITY; PRINCIPAL COMPONENT ANALYSIS; SKELETAL MUSCLE; WEIGHT GAIN; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; BIOMARKERS; DIET, HIGH-FAT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE INTOLERANCE; LIVER; MALE; MICE, INBRED C57BL; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; NAD; NICOTINAMIDE N-METHYLTRANSFERASE; OBESITY; ORGAN SPECIFICITY; PRINCIPAL COMPONENT ANALYSIS; SIRTUINS; TRYPTOPHAN OXYGENASE; WEIGHT GAIN;

EID: 84984824826     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.07.013     Document Type: Article

References (39)

1. [1] Haigis, MC, Sinclair, DA, Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5 (2010), 253–295.
2. [2] Dong, XC, Sirtuin biology and relevance to diabetes treatment. Diabetes Manag (Lond) 2 (2012), 243–257.
3. [3] Huynh, FK, Hershberger, KA, Hirschey, MD, Targeting sirtuins for the treatment of diabetes. Diabetes Manag (Lond) 3 (2013), 245–257.
4. [4] Williams, LW, Campbell, FM, Drew, JE, Koch, C, Hoggard, NM, Rees, WD, et al. The development of diet-induced obesity and glucose intolerance in C57Bl/6 mice on a high-fat diet consists of distinct phases. PLoS One, 9, 2014, e106159.
5. [5] Pfluger, PT, Herranz, D, Velasco-Miguel, S, Serrano, M, Tschöp, MH, Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105 (2008), 9793–9798.
6. [6] Houtkooper, RH, Pirinen, E, Auwerx, J, Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13 (2012), 225–238.
7. [7] Caron, AZ, He, X, Mottawea, W, Seifert, EL, Jardine, K, Dewar-Darch, D, et al. The SIRT1 deacetylase protects mice against the symptoms of metabolic syndrome. FASEB J 28 (2014), 1306–1316.
8. [8] Drew, JE, Farquharson, AJ, Horgan, GW, Duthie, SJ, Duthie, GG, Stratification of study subjects detected by gene expression profiling reveals differences in postprandial cell defence system responses. Mol Nutr Food Res 58 (2014), 2066–2079.
9. [9] Bogan, KL, Brenner, C, Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28 (2008), 115–130.
10. [10] Kendrick, AA, Choudhury, M, Rahman, SM, McCurdy, CE, Friederich, M, Van Hove, JL, et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J 433 (2011), 505–514.
11. [11] Ishikawa, S, Li, G, Takemitsu, H, Fujiwara, M, Mori, N, Yamamoto, I, et al. Change in mRNA expression of sirtuin 1 and sirtuin 3 in cats fed on high fat diet. BMC Vet Res, 9, 2013, 187.
12. [12] de Kreutzenberg, SV, Ceolotto, G, Papparella, I, Bortoluzzi, A, Semplicini, A, Dalla Man, C, et al. Down-regulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59 (2010), 1006–1015.
13. [13] Hirschey, MD, Shimazu, T, Jing, E, Grueter, CA, Collins, AM, Aouizerat, B, et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44 (2011), 177–190.
14. [14] Yoshino, J, Mills, KF, Yoon, MJ, Imai, S, Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14 (2011), 528–536.
15. [15] Chang, HC, Guarente, L, SIRT1 and other sirtuins in metabolism. Trends Endocrinol Metab 25 (2014), 138–145.
16. [16] Nasrin, N, Wu, X, Fortier, E, Feng, Y, Bare, OC, Chen, S, et al. SIRT4 regulates fatty acid oxidation and mitochondrial gene expression in liver and muscle cells. J Biol Chem 285 (2010), 31995–32002.
17. [17] Laurent, G, de Boer, VC, Finley, LW, Sweeney, M, Lu, H, Schug, TT, et al. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation. Mol Cell Biol 33 (2013), 4552–4561.
18. [18] Hara, N, Yamada, K, Shibata, T, Osago, H, Hashimoto, T, Tsuchiya, M, et al. Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells. J Biol Chem 282 (2007), 24574–24582.
19. [19] Penke, M, Larsen, PS, Schuster, S, Dall, M, Jensen, BA, Gorski, T, et al. Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. Mol Cell Endocrinol 412 (2015), 65–72.
20. [20] Berger, F, Lau, C, Dahlmann, M, Ziegler, M, Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280 (2005), 36334–36341.
21. [21] Rhee, HW, Zou, P, Udeshi, ND, Martell, JD, Mootha, VK, Carr, SA, et al. Proteomic mapping of mitochondria in living cells via spatially restricted enzymatic tagging. Science 339 (2013), 1328–1331.
22. [22] Felici, R, Lapucci, A, Ramazzotti, M, Chiarugi, A, Insight into molecular and functional properties of NMNAT3 reveals new hints of NAD homeostasis within human mitochondria. PLoS One, 8, 2013, e76938.
23. [23] Oram, JF, Lawn, RM, ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42 (2001), 1173–1179.
24. [24] de Haan, W, Karasinska, JM, Ruddle, P, Hayden, MR, Hepatic ABCA1 expression improves β-cell function and glucose tolerance. Diabetes 63 (2014), 4076–4082.
25. [25] Kraus, D, Yang, Q, Kong, D, Banks, AS, Zhang, L, Rodgers, JT, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508 (2014), 258–262.
26. [26] Kannt, A, Pfenninger, A, Teichert, L, Tönjes, A, Dietrich, A, Schön, MR, et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 58 (2015), 799–808.
27. [27] Giuliante, R, Sartini, D, Bacchetti, T, Rocchetti, R, Klöting, I, Polidori, C, et al. Potential involvement of nicotinamide n-methyltransferase in the pathogenesis of metabolic syndrome. Metab Syndr Relat Disord 13 (2015), 165–170.
28. [28] Sartini, D, Muzzonigro, G, Milanese, G, Pozzi, V, Vici, A, Morganti, S, et al. Up-regulation of tissue and urinary nicotinamide N-methyltransferase in bladder cancer: potential for the development of a urine-based diagnostic test. Cell Biochem Biophys 65 (2013), 473–483.
29. [29] Zhou, W, Gui, M, Zhu, M, Long, Z, Huang, L, Zhou, J, et al. Nicotinamide N-methyltransferase is overexpressed in prostate cancer and correlates with prolonged progression-free and overall survival times. Oncol Lett 8 (2014), 1175–1180.
30. [30] Lu, CT, Hsu, CM, Lin, PM, Lai, CC, Lin, HC, Yang, CH, et al. The potential of SIRT6 and SIRT7 as circulating markers for head and neck squamous cell carcinoma. Anticancer Res 34 (2014), 7137–7143.
31. [31] Kiran, S, Anwar, T, Kiran, M, Ramakrishna, G, Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh sirtuin!. Cell Signal 27 (2015), 673–682.
32. [32] Byers, T, Sedjo, RL, Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocr Relat Cancer 22 (2015), R125–R134.
33. [33] Hong, S, Moreno-Navarrete, JM, Wei, X, Kikukawa, Y, Tzameli, I, Prasad, D, Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med 21 (2015), 887–894.
34. [34] Bieganowski, P, Brenner, C, Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-handler independent route to NAD+ in fungi and humans. Cell 117 (2004), 495–502.
35. [35] Chi, Y, Sauve, AA, Nicotinamide riboside, a trace nutrient in foods, is a vitamin B3 with effects on energy metabolism and neuroprotection. Curr Opin Clin Nutr Metab Care 16 (2013), 657–661.
36. [36] Barbosa, MT, Soares, SM, Novak, CM, Sinclair, D, Levine, JA, Aksoy, P, et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 21 (2007), 3629–3639.
37. [37] Malavasi, F, Deaglio, S, Funaro, A, Ferrero, E, Horenstein, AL, Ortolan, E, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev 88 (2008), 841–886.
38. [38] Christensen, CE, Karlsson, M, Winther, JR, Jensen, PR, Lerche, MH, Non-invasive in-cell determination of free cytosolic [NAD+]/[NADH] ratios using hyperpolarized glucose show large variations in metabolic phenotypes. J Biol Chem 289 (2014), 2344–2352.
39. [39] Ruggieri, S, Orsomando, G, Sorci, L, Raffaelli, N, Regulation of NAD biosynthetic enzymes modulates NAD-sensing processes to shape mammalian cell physiology under varying biological cues. Biochim Biophys Acta 2015 (1854), 1138–1149.